48 related articles for article (PubMed ID: 37310797)
21. Quality of life and psychological well-being of breast cancer survivors in Jordan.
Abu-Helalah M; Al-Hanaqta M; Alshraideh H; Abdulbaqi N; Hijazeen J
Asian Pac J Cancer Prev; 2014; 15(14):5927-36. PubMed ID: 25081724
[TBL] [Abstract][Full Text] [Related]
22. Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial.
Campone M; De Laurentiis M; Zamagni C; Kudryavcev I; Agterof M; Brown-Glaberman U; Palácová M; Chatterjee S; Menon-Singh L; Wu J; Martín M
Breast Cancer Res Treat; 2022 May; 193(1):95-103. PubMed ID: 35212906
[TBL] [Abstract][Full Text] [Related]
23. Randomized Controlled Trials 4: Planning, Analysis, and Interpretation of Quality-of-Life Studies.
Foley RN; Parfrey PS
Methods Mol Biol; 2021; 2249():247-259. PubMed ID: 33871848
[TBL] [Abstract][Full Text] [Related]
24. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials.
Corrigan KL; Mainwaring W; Miller AB; Lin TA; Jethanandani A; Espinoza AF; Piotrowski M; Fuller CD; Stauder MC; Shaitelman SF; Perkins GH; Woodward WA; Giordano SH; Smith BD; Ludmir EB
Oncologist; 2020 Jun; 25(6):e990-e992. PubMed ID: 32272505
[TBL] [Abstract][Full Text] [Related]
25. Management of Male Breast Cancer: ASCO Guideline.
Hassett MJ; Somerfield MR; Baker ER; Cardoso F; Kansal KJ; Kwait DC; Plichta JK; Ricker C; Roshal A; Ruddy KJ; Safer JD; Van Poznak C; Yung RL; Giordano SH
J Clin Oncol; 2020 Jun; 38(16):1849-1863. PubMed ID: 32058842
[TBL] [Abstract][Full Text] [Related]
26. Unmet information needs of men with breast cancer and health professionals.
Bootsma TI; Duijveman P; Pijpe A; Scheelings PC; Witkamp AJ; Bleiker EMA
Psychooncology; 2020 May; 29(5):851-860. PubMed ID: 32040237
[TBL] [Abstract][Full Text] [Related]
27. Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer.
Mierzynska J; Taye M; Pe M; Coens C; Martinelli F; Pogoda K; Velikova G; Bjelic-Radisic V; Cardoso F; Brain E; Ignatiadis M; Piccart M; Van Tienhoven G; Mansel R; Wildiers H; Bottomley A;
Eur J Cancer; 2020 Jan; 125():69-82. PubMed ID: 31838407
[TBL] [Abstract][Full Text] [Related]
28. Breast Cancer in Men.
Giordano SH
N Engl J Med; 2018 Oct; 379(14):1385-1386. PubMed ID: 30281998
[No Abstract] [Full Text] [Related]
29. Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.
Adam S; Feller A; Rohrmann S; Arndt V
Health Qual Life Outcomes; 2018 Jan; 16(1):22. PubMed ID: 29361950
[TBL] [Abstract][Full Text] [Related]
30. The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset.
Cuypers M; Lamers RED; Cornel EB; van de Poll-Franse LV; de Vries M; Kil PJM
Support Care Cancer; 2018 Apr; 26(4):1297-1304. PubMed ID: 29127529
[TBL] [Abstract][Full Text] [Related]
31. Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program.
Cardoso F; Bartlett JMS; Slaets L; van Deurzen CHM; van Leeuwen-Stok E; Porter P; Linderholm B; Hedenfalk I; Schröder C; Martens J; Bayani J; van Asperen C; Murray M; Hudis C; Middleton L; Vermeij J; Punie K; Fraser J; Nowaczyk M; Rubio IT; Aebi S; Kelly C; Ruddy KJ; Winer E; Nilsson C; Lago LD; Korde L; Benstead K; Bogler O; Goulioti T; Peric A; Litière S; Aalders KC; Poncet C; Tryfonidis K; Giordano SH
Ann Oncol; 2018 Feb; 29(2):405-417. PubMed ID: 29092024
[TBL] [Abstract][Full Text] [Related]
32. Psychological impact of male breast disorders: literature review and survey results.
Kipling M; Ralph JE; Callanan K
Breast Care (Basel); 2014 Feb; 9(1):29-33. PubMed ID: 24803884
[TBL] [Abstract][Full Text] [Related]
33. European reference values for the quality of life questionnaire EORTC QLQ-C30: Results of a German investigation and a summarizing analysis of six European general population normative studies.
Hinz A; Singer S; Brähler E
Acta Oncol; 2014 Jul; 53(7):958-65. PubMed ID: 24456505
[TBL] [Abstract][Full Text] [Related]
34. Quality of life and symptoms in male breast cancer survivors.
Ruddy KJ; Giobbie-Hurder A; Giordano SH; Goldfarb S; Kereakoglow S; Winer EP; Partridge AH
Breast; 2013 Apr; 22(2):197-199. PubMed ID: 23313328
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen adherence and its relationship to mortality in 116 men with breast cancer.
Xu S; Yang Y; Tao W; Song Y; Chen Y; Ren Y; Liu J; Pang D
Breast Cancer Res Treat; 2012 Nov; 136(2):495-502. PubMed ID: 23065002
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality of life in male breast cancer patients.
Kowalski C; Steffen P; Ernstmann N; Wuerstlein R; Harbeck N; Pfaff H
Breast Cancer Res Treat; 2012 Jun; 133(2):753-7. PubMed ID: 22315132
[TBL] [Abstract][Full Text] [Related]
37. Retrospective review of male breast cancer patients: analysis of tamoxifen-related side-effects.
Pemmaraju N; Munsell MF; Hortobagyi GN; Giordano SH
Ann Oncol; 2012 Jun; 23(6):1471-4. PubMed ID: 22085764
[TBL] [Abstract][Full Text] [Related]
38. Male breast carcinoma: increased awareness needed.
White J; Kearins O; Dodwell D; Horgan K; Hanby AM; Speirs V
Breast Cancer Res; 2011 Sep; 13(5):219. PubMed ID: 22017761
[TBL] [Abstract][Full Text] [Related]
39. Physical and mental health status and health behaviors in male breast cancer survivors: a national, population-based, case-control study.
Andrykowski MA
Psychooncology; 2012 Sep; 21(9):927-34. PubMed ID: 21695746
[TBL] [Abstract][Full Text] [Related]
40. Endocrine therapy for male breast cancer: rates of toxicity and adherence.
Visram H; Kanji F; Dent SF
Curr Oncol; 2010 Oct; 17(5):17-21. PubMed ID: 20975874
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
